IBDEI07K ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7480,0)
 ;;=C82.49^^42^498^70
 ;;^UTILITY(U,$J,358.3,7480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7480,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,7480,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,7480,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,7481,0)
 ;;=C82.40^^42^498^71
 ;;^UTILITY(U,$J,358.3,7481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7481,1,3,0)
 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
 ;;^UTILITY(U,$J,358.3,7481,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,7481,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,7482,0)
 ;;=C82.99^^42^498^72
 ;;^UTILITY(U,$J,358.3,7482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7482,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,7482,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,7482,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,7483,0)
 ;;=C82.90^^42^498^73
 ;;^UTILITY(U,$J,358.3,7483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7483,1,3,0)
 ;;=3^Follicular Lymphoma Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,7483,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,7483,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,7484,0)
 ;;=R59.1^^42^498^58
 ;;^UTILITY(U,$J,358.3,7484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7484,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Generalized
 ;;^UTILITY(U,$J,358.3,7484,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,7484,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,7485,0)
 ;;=C91.40^^42^498^77
 ;;^UTILITY(U,$J,358.3,7485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7485,1,3,0)
 ;;=3^Hairy Cell Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,7485,1,4,0)
 ;;=4^C91.40
 ;;^UTILITY(U,$J,358.3,7485,2)
 ;;=^5001771
 ;;^UTILITY(U,$J,358.3,7486,0)
 ;;=C91.42^^42^498^75
 ;;^UTILITY(U,$J,358.3,7486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7486,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,7486,1,4,0)
 ;;=4^C91.42
 ;;^UTILITY(U,$J,358.3,7486,2)
 ;;=^5001773
 ;;^UTILITY(U,$J,358.3,7487,0)
 ;;=C91.41^^42^498^76
 ;;^UTILITY(U,$J,358.3,7487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7487,1,3,0)
 ;;=3^Hairy Cell Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,7487,1,4,0)
 ;;=4^C91.41
 ;;^UTILITY(U,$J,358.3,7487,2)
 ;;=^5001772
 ;;^UTILITY(U,$J,358.3,7488,0)
 ;;=D57.01^^42^498^78
 ;;^UTILITY(U,$J,358.3,7488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7488,1,3,0)
 ;;=3^Hb-SS Disease w/ Acute Chest Syndrome
 ;;^UTILITY(U,$J,358.3,7488,1,4,0)
 ;;=4^D57.01
 ;;^UTILITY(U,$J,358.3,7488,2)
 ;;=^5002307
 ;;^UTILITY(U,$J,358.3,7489,0)
 ;;=D57.00^^42^498^79
 ;;^UTILITY(U,$J,358.3,7489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7489,1,3,0)
 ;;=3^Hb-SS Disease w/ Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,7489,1,4,0)
 ;;=4^D57.00
 ;;^UTILITY(U,$J,358.3,7489,2)
 ;;=^5002306
 ;;^UTILITY(U,$J,358.3,7490,0)
 ;;=D57.02^^42^498^80
 ;;^UTILITY(U,$J,358.3,7490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7490,1,3,0)
 ;;=3^Hb-SS Disease w/ Splenic Sequestration
 ;;^UTILITY(U,$J,358.3,7490,1,4,0)
 ;;=4^D57.02
 ;;^UTILITY(U,$J,358.3,7490,2)
 ;;=^5002308
 ;;^UTILITY(U,$J,358.3,7491,0)
 ;;=D68.32^^42^498^82
 ;;^UTILITY(U,$J,358.3,7491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7491,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,7491,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,7491,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,7492,0)
 ;;=C22.2^^42^498^83
 ;;^UTILITY(U,$J,358.3,7492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7492,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,7492,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,7492,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,7493,0)
 ;;=D58.9^^42^498^85
 ;;^UTILITY(U,$J,358.3,7493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7493,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,7493,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,7493,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,7494,0)
 ;;=C81.99^^42^498^86
 ;;^UTILITY(U,$J,358.3,7494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7494,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,7494,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,7494,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,7495,0)
 ;;=C81.90^^42^498^87
 ;;^UTILITY(U,$J,358.3,7495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7495,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,7495,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,7495,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,7496,0)
 ;;=D89.2^^42^498^88
 ;;^UTILITY(U,$J,358.3,7496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7496,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,7496,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,7496,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,7497,0)
 ;;=D05.12^^42^498^89
 ;;^UTILITY(U,$J,358.3,7497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7497,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,7497,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,7497,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,7498,0)
 ;;=D05.11^^42^498^90
 ;;^UTILITY(U,$J,358.3,7498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7498,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,7498,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,7498,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,7499,0)
 ;;=D05.10^^42^498^91
 ;;^UTILITY(U,$J,358.3,7499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7499,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,7499,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,7499,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,7500,0)
 ;;=D50.0^^42^498^92
 ;;^UTILITY(U,$J,358.3,7500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7500,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,7500,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,7500,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,7501,0)
 ;;=D50.9^^42^498^93
 ;;^UTILITY(U,$J,358.3,7501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7501,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,7501,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,7501,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,7502,0)
 ;;=C46.9^^42^498^94
 ;;^UTILITY(U,$J,358.3,7502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7502,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,7502,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,7502,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,7503,0)
 ;;=C22.0^^42^498^95
 ;;^UTILITY(U,$J,358.3,7503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7503,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,7503,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,7503,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,7504,0)
 ;;=D05.02^^42^498^96
 ;;^UTILITY(U,$J,358.3,7504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7504,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,7504,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,7504,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,7505,0)
 ;;=D05.01^^42^498^97
 ;;^UTILITY(U,$J,358.3,7505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7505,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,7505,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,7505,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,7506,0)
 ;;=D05.00^^42^498^98
 ;;^UTILITY(U,$J,358.3,7506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7506,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,7506,1,4,0)
 ;;=4^D05.00
 ;;^UTILITY(U,$J,358.3,7506,2)
 ;;=^5001926
 ;;^UTILITY(U,$J,358.3,7507,0)
 ;;=R59.0^^42^498^59
 ;;^UTILITY(U,$J,358.3,7507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7507,1,3,0)
 ;;=3^Enlarged Lymph Nodes,Localized
 ;;^UTILITY(U,$J,358.3,7507,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,7507,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,7508,0)
 ;;=C83.59^^42^498^99
